Xintela Ab Stock Fundamentals
| XINT Stock | SEK 0.33 0.01 3.13% |
Xintela AB fundamentals help investors to digest information that contributes to Xintela AB's financial success or failures. It also enables traders to predict the movement of Xintela Stock. The fundamental analysis module provides a way to measure Xintela AB's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xintela AB stock.
Xintela |
Xintela AB Company Price To Earning Analysis
Xintela AB's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Xintela AB Price To Earning | (4.40) X |
Most of Xintela AB's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Xintela AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Xintela AB has a Price To Earning of -4.4 times. This is 117.03% lower than that of the Healthcare sector and 189.25% lower than that of the Biotechnology industry. The price to earning for all Sweden stocks is 115.32% higher than that of the company.
Xintela AB Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Xintela AB's current stock value. Our valuation model uses many indicators to compare Xintela AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Xintela AB competition to find correlations between indicators driving Xintela AB's intrinsic value. More Info.Xintela AB is rated first in return on equity category among its peers. It is rated first in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Xintela AB's earnings, one of the primary drivers of an investment's value.Xintela Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Xintela AB's direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Xintela AB could also be used in its relative valuation, which is a method of valuing Xintela AB by comparing valuation metrics of similar companies.Xintela AB is currently under evaluation in price to earning category among its peers.
Xintela Fundamentals
| Return On Equity | -4.69 | |||
| Return On Asset | -1.14 | |||
| Current Valuation | 122.93 M | |||
| Shares Outstanding | 307.57 M | |||
| Shares Owned By Insiders | 58.76 % | |||
| Price To Earning | (4.40) X | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 5,115 X | |||
| Gross Profit | 2.08 M | |||
| EBITDA | (54.43 M) | |||
| Net Income | (58.39 M) | |||
| Cash And Equivalents | 11.14 M | |||
| Cash Per Share | 0.53 X | |||
| Current Ratio | 6.13 X | |||
| Book Value Per Share | (0.01) X | |||
| Cash Flow From Operations | (42.89 M) | |||
| Earnings Per Share | (0.73) X | |||
| Number Of Employees | 16 | |||
| Beta | 1.45 | |||
| Market Capitalization | 143.79 M | |||
| Total Asset | 24.74 M | |||
| Z Score | -6.6 | |||
| Net Asset | 24.74 M |
About Xintela AB Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xintela AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xintela AB using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xintela AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Xintela AB , a biomedical company, operates in the fields of regenerative medicine and cancer, focusing on cartilage damage and brain tumors. The company was founded in 2009 and is based in Lund, Sweden. Xintela AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 13 people.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Xintela Stock Analysis
When running Xintela AB's price analysis, check to measure Xintela AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Xintela AB is operating at the current time. Most of Xintela AB's value examination focuses on studying past and present price action to predict the probability of Xintela AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Xintela AB's price. Additionally, you may evaluate how the addition of Xintela AB to your portfolios can decrease your overall portfolio volatility.